Fluid, Electrolyte and Acid Base Disorders

📚 01 General Pediatrics • 🎯 40 High-Yield MCQs • Nelson 22nd Edition Standard

Body Fluid Compartments and Tonicity

  • Extracellular Fluid (ECF) Transitions: ((FEAB001)): At birth, ECF volume exceeds intracellular fluid (ICF) volume due to high water content and lower fat/muscle mass. Following postnatal diuresis, ICF expands while ECF drops, with the ICF-to-ECF ratio approaching adult values by 1 year of age (Adult ICF: 30–40%, ECF: 20–25%).
  • Major Cations: ((FEAB002)): Sodium ($Na^+$) (~140 mEq/L) and Calcium ($Ca^{2+}$) (~2.5 mEq/L) are the principal cations in the extracellular fluid. Potassium (~140 mEq/L) and Magnesium (~7 mEq/L) are predominantly intracellular.
  • Effective Osmolality (Tonicity): ((FEAB003)): Includes $Na^+$, glucose, and other impermeable solutes. Urea does not contribute to effective osmolality because it crosses cell membranes freely and distributes equally across compartments.
  • Plasma Osmolality Range: ((FEAB004)): Tightly regulated between 285–295 mOsm/kg.
  • Maintenance Water Needs Adjustments: ((FEAB019)): Humidified respiratory circuits reduce evaporative water loss and decrease maintenance requirements; conversely, radiant warmers, phototherapy, fever, tachypnea, diarrhea, and polyuria increase water needs.
  • Maintenance IV Fluid Goals: ((FEAB031)): Maintenance fluids prevent dehydration, electrolyte disorders, and starvation ketoacidosis; they are not intended for rapid intravascular volume expansion.
  • Maintenance Fluid Calculation: ((FEAB032)): Calculated via the 100/50/20 rule (100 mL/kg for first 10 kg, 50 mL/kg for next 10 kg, 20 mL/kg for each kg thereafter; maximum daily total typically ≤2,400 mL/day).

Sodium Disorders and Water Balance

  • Complications of Hypernatremia: ((FEAB005)): Brain hemorrhage is the most devastating complication. Brain shrinkage pulls parenchyma away from the skull, tearing bridging veins and small vessels (leading to subarachnoid/subdural/parenchymal bleeds).
  • CSF Findings in Hypernatremia: ((FEAB021)): Severe hypernatremia can cause elevated CSF protein due to vascular leakage from stretched/damaged intracranial vessels, despite normal cell counts and glucose.
  • Hypernatremia Management (Acute vs. Chronic): ((((FEAB022)) · ((FEAB023)))): - Rapid over-correction (e.g., dropping $Na^+$ by 18 mEq/L in 6 hours) causes acute cerebral edema due to idiogenic osmoles; treat acute neurological symptoms (seizures) with a 3% hypertonic saline bolus. - In sodium intoxication/overload with pulmonary edema and oliguria, large volumes of free water (e.g., $D_5W$) are contraindicated; dialysis is required to remove excess sodium and control volume.
  • Pseudohyponatremia: ((FEAB006)): Caused by severe hypertriglyceridemia or hyperproteinemia (lipemic serum, multiple myeloma, post-IVIG). Indirect ion-selective electrodes measure low $Na^+$ due to increased non-aqueous solid fraction, while measured plasma osmolality remains normal and direct ISE/ABG analyzer values are accurate.
  • Syndrome of Inappropriate Antidiuretic Hormone (SIADH): ((((FEAB007)) · ((FEAB024)))): - Diagnostic criteria: Hypotonic hyponatremia ($Na^+$ <135 mEq/L, serum osmolality <280 mOsm/kg), urine osmolality >100 mOsm/kg (inappropriately concentrated), urine $Na^+$ >30 mEq/L, euvolemia, low BUN, low serum uric acid, and normal adrenal/thyroid/renal function. - Differential: Cerebral Salt Wasting (CSW) presents with hypovolemia, high urine output, and high urine $Na^+$, requiring salt/volume replacement rather than fluid restriction. - Triggers: Carbamazepine, SSRIs, TCAs, vincristine, cyclophosphamide, and MDMA. - Vaptans: Vasopressin receptor antagonists promoting aquaresis; contraindicated in patients with moderate to severe CNS symptoms.
  • Symptomatic Hyponatremia Management: ((FEAB025)): Seizures or coma demand immediate intervention with a 3% hypertonic saline bolus (4–6 mL/kg) to rapidly draw water out of swollen brain cells (each 1 mL/kg of 3% saline raises $Na^+$ by ~1 mEq/L).

Potassium, Magnesium, and Phosphate Homeostasis

  • Renal Potassium Regulation: ((((FEAB010)) · ((FEAB012)))): - Aldosterone is the principal regulator, acting on the cortical collecting duct to stimulate $Na^+$ reabsorption via ENaC and enhance $K^+$ secretion. - Loop diuretics (furosemide) cause hypokalemia by increasing distal sodium delivery and flow. - Liddle syndrome: Autosomal dominant gain-of-function of ENaC causing early-onset hypertension, hypokalemic metabolic alkalosis, low renin, and low aldosterone (pseudoaldosteronism). Treated with amiloride/triamterene (spironolactone is ineffective).
  • Hyperkalemia Management: ((FEAB011)): - Acute stabilization: IV calcium gluconate (protects cardiac membrane), IV insulin + dextrose, and nebulized albuterol. - Patiromer is a slow-acting oral resin used exclusively for chronic hyperkalemia, not for emergency settings.
  • Hypokalemia Workup: ((FEAB026)): Transtubular potassium gradient (tTKG) distinguishes renal from extrarenal losses: tTKG ≤2 indicates appropriate renal conservation (e.g., diarrhea); tTKG >4 indicates renal $K^+$ wasting (e.g., diuretics, Bartter/Gitelman).
  • Magnesium Homeostasis: ((((FEAB013)) · ((FEAB027)))): - The thick ascending limb (TAL) of the loop of Henle reabsorbs ~70% of filtered $Mg^{2+}$ via paracellular transport driven by a lumen-positive potential. - Severe symptomatic hypomagnesemia ($Mg^{2+}$ <1 mg/dL with seizures/tetany/QT prolongation) mandates parenteral magnesium sulfate (25–50 mg/kg slow IV infusion).
  • Phosphate Disorders and Refeeding Syndrome: ((((FEAB014)) · ((FEAB015)) · ((FEAB028)))): - Hyperphosphatemia: Most commonly caused by renal insufficiency (impaired renal excretion). - Refeeding Syndrome: Rapid anabolism drives phosphate into cells, causing profound hypophosphatemia within the first 5 days. - Complications: Acute hypophosphatemia commonly precipitates rhabdomyolysis (myalgias, dark urine, markedly elevated CK, rising creatinine) alongside potential hemolytic anemia and respiratory failure.

Acid-Base Disorders

  • D-Lactic Acidosis: ((FEAB016)): Seen in short bowel syndrome with bacterial overgrowth fermenting carbohydrates into D-lactate. Manifests with high anion gap metabolic acidosis and neurological symptoms (confusion, ataxia), but standard assays show a normal routine (L-)lactate level.
  • Metabolic Acidosis Classification: ((FEAB017)): - High Anion Gap Metabolic Acidosis (HAGMA): Diabetic ketoacidosis (DKA), lactic acidosis, salicylates, uremia, toxic alcohols. - Normal Anion Gap Metabolic Acidosis (NAGMA / Hyperchloremic): Diarrhea, distal (type 1) or proximal (type 2) RTA, urinary diversion.
  • Metabolic Alkalosis Classification: ((FEAB018)): - Chloride-Responsive (Urine $Cl^-$ <15 mEq/L): Vomiting, NG suction, prior diuretic use, chloride-losing diarrhea. - Chloride-Resistant (Urine $Cl^-$ >20 mEq/L): Bartter syndrome (salt-wasting tubulopathy, normotensive), Gitelman syndrome, current diuretic use.
  • Metabolic Acidosis Compensation (Winter’s Formula): ((FEAB029)): Expected $PCO_2$ = $1.5 \times [HCO_3^-] + 8 \pm 2$. Matching measured $PCO_2$ confirms appropriate respiratory compensation (e.g., Kussmaul hyperventilation in DKA).
  • Metabolic Alkalosis Manifestations: ((FEAB030)): Characterized by volume depletion (thirst, lethargy), carpopedal spasm from reduced ionized calcium, and increased arrhythmia risk (especially with hypokalemia). Kussmaul respirations are unique to metabolic acidosis, not alkalosis (which features compensatory hypoventilation/elevated $PCO_2$).

Dehydration Assessment and Ongoing Fluid Management

  • Dehydration Grading: ((FEAB033)): - Moderate Dehydration (5–10% deficit): Tachycardia, sunken eyes/fontanelle, decreased tears, dry mucous membranes, oliguria, cool/pale extremities, and capillary refill of ~2 seconds with normal blood pressure.
  • Ongoing Diarrheal Loss Replacement: ((FEAB020)): Nelson recommends $D_5\frac{1}{2}NS$ supplemented with 30 mEq/L sodium bicarbonate and 20 mEq/L $KCl$, replaced mL-for-mL every 1–6 hours.

Electrolyte Disorders, Fluid Management, and Channelopathies

  • Pseudohyperkalemia & Blood Draw Artifact: ((FEAB036)): - Crucial Rule: Pediatric hyperkalemia in an asymptomatic, well-appearing child with normal ECG, normal renal function, and absent hemolysis requires ruling out artifact. - Prolonged tourniquet time, aggressive fist clenching, and traumatic venipuncture release intracellular $K^+$ from muscle, causing spurious elevation. - Mandatory Action: Repeat a prompt plasma potassium using an atraumatic, free-flowing draw without a tight tourniquet before initiating treatment. - Distractors: Avoid starting insulin-dextrose (used for true, ECG-verified hyperkalemia). Tumor lysis syndrome features hyperuricemia, hyperphosphatemia, acute kidney injury, and underlying malignancy/chemotherapy.
  • Hyperkalemic Periodic Paralysis: ((FEAB037)):
  • Hyperkalemic Periodic Paralysis: is an autosomal dominant channelopathy caused by ==gain-of-function variants in SCN4A* (encoding the skeletal muscle voltage-gated sodium channel, Naᵥ1.4*). - Clinical Hallmark: Recurrent brief episodes (30–90 minutes) of flaccid weakness triggered by rest following vigorous exercise, potassium-rich snacks, or cold exposure. - Serum $K^+$ is elevated or normal during attacks; interictal period shows mild myotonia on handgrip. - Distractors: CACNA1S mutations are linked to hypokalemic periodic paralysis type 1.
  • Primary Hypomagnesemia with Secondary Hypocalcemia (HSH): ((FEAB038)):
  • HSH: is an autosomal recessive disorder caused by variants in TRPM6, encoding a transient receptor potential channel responsible for intestinal magnesium absorption and renal magnesium conservation. - Clinical Hallmark: Infants present at 2–8 weeks of life with refractory seizures, tremors, irritability, and tetany. - Diagnostic Cutoff: Severe hypomagnesemia (0.2–0.8 mg/dL; normal usually >1.7 mg/dL) causing refractory hypocalcemia that fails to respond to calcium therapy until magnesium is repleted. - Distractors: GNAS mutations cause pseudohypoparathyroidism (hypocalcemia with hyperphosphatemia due to PTH resistance, not profound hypomagnesemia). CASR mutations cause familial hypocalciuric hypercalcemia or neonatal severe primary hyperparathyroidism. SLC12A3 mutations cause Gitelman syndrome (older children/adults with hypokalemic metabolic alkalosis and hypomagnesemia).
  • Fluid Resuscitation in Metabolic Alkalosis: ((FEAB039)): - Clinical Rule: For severe pediatric dehydration with shock, administer isotonic fluid boluses (0.9% Normal Saline at 20 mL/kg over 20 minutes). - Special Scenario: In persistent vomiting leading to metabolic alkalosis, 0.9% Normal Saline (NS) is the preferred resuscitation fluid due to its high chloride content. - Distractors: Ringer's lactate (LR) is contraindicated or less ideal because lactate is metabolized to bicarbonate, which can worsen metabolic alkalemia. 5% Dextrose in Water (D5W) and 0.45% Saline are hypotonic and inappropriate for acute volume resuscitation in shock.
  • ECG Manifestations of Hyperkalemia: ((FEAB040)):
  • Hyperkalemia: (common in advanced CKD or missed dialysis) produces a characteristic, sequential ECG progression: 1. Tall, narrow, peaked ("tented") T waves (earliest sign) 2. PR prolongation and ST-segment depression 3. Flattening and eventual disappearance of P waves 4. Progressive QRS widening 5. Progression to a classic sine-wave pattern, leading directly to ventricular fibrillation or asystole. - Distractors: Hypokalemia produces flattened/inverted T waves, ST depression, QT prolongation, and prominent U waves (the exact opposite of peaked T waves).